AbstractObjectivesThe aim of this study was to identify predictors for longterm survival following pancreaticoduodenectomy (PD) for pancreatic and other periampullary adenocarcinomas.MethodsClinicopathological factors were compared between short-term (<5 years) and longterm (≥5 years) survival groups. Rates of actual 5-year and actuarial 10-year survival were determined.ResultsThere were 109 (21.8%) longterm survivors among a sample of 501 patients. Patients with ampullary adenocarcinoma represented 76.1% of the longterm survivors. Favourable factors for longterm survival included female gender, lack of jaundice, lower blood loss, classical PD, absence of postoperative bleeding or intra-abdominal abscess, non-pancreatic primary cancer, earl...
BACKGROUND: Long-term survival (LTS) in patients (pts) with pancreatic cancer is still uncommon, lit...
Objective: To study the impact of perineural growth as a prognostic factor in periampullary adenocar...
Actual 5-year survival rates of 10–18% have been reported for patients with resected pancreatic aden...
Background: pancreatoduodenectomy (PD) is recommended in fit patients with a resectable ampullary ad...
none15Context Pancreatic ductal adenocarcinoma is generally associated with a dismal prognosis even ...
Background: The diagnosis and treatment of periampullary tumors represents a challenge for current m...
Abstract Background The prognosis of patients with periampullary adenocarcinoma after pancreatoduode...
BACKGROUND: The aim of this study was to determine prognostic factors for survival after pancreatico...
AbstractObjectiveThis study was carried out to determine relative survival rates and trends in outco...
AbstractPancreatic cancer remains a lethal disease. Although there are many reports on the survival ...
Evaluation of prognostic factors of adenocarcinoma of Vater's ampulla is still a matter of debate. T...
BACKGROUND: Results of pancreaticoduodenectomy for ampullary carcinoma were evaluated, and prognosti...
International audienceBACKGROUND Ampullary adenocarcinoma (AAC) is a rare neoplasm that accounts for...
A retrospective study was performed of 113 patients who underwent surgical resection of carcinoma of...
International audienceBACKGROUND:Predictors of recurrence following pancreaticoduodenectomy are well...
BACKGROUND: Long-term survival (LTS) in patients (pts) with pancreatic cancer is still uncommon, lit...
Objective: To study the impact of perineural growth as a prognostic factor in periampullary adenocar...
Actual 5-year survival rates of 10–18% have been reported for patients with resected pancreatic aden...
Background: pancreatoduodenectomy (PD) is recommended in fit patients with a resectable ampullary ad...
none15Context Pancreatic ductal adenocarcinoma is generally associated with a dismal prognosis even ...
Background: The diagnosis and treatment of periampullary tumors represents a challenge for current m...
Abstract Background The prognosis of patients with periampullary adenocarcinoma after pancreatoduode...
BACKGROUND: The aim of this study was to determine prognostic factors for survival after pancreatico...
AbstractObjectiveThis study was carried out to determine relative survival rates and trends in outco...
AbstractPancreatic cancer remains a lethal disease. Although there are many reports on the survival ...
Evaluation of prognostic factors of adenocarcinoma of Vater's ampulla is still a matter of debate. T...
BACKGROUND: Results of pancreaticoduodenectomy for ampullary carcinoma were evaluated, and prognosti...
International audienceBACKGROUND Ampullary adenocarcinoma (AAC) is a rare neoplasm that accounts for...
A retrospective study was performed of 113 patients who underwent surgical resection of carcinoma of...
International audienceBACKGROUND:Predictors of recurrence following pancreaticoduodenectomy are well...
BACKGROUND: Long-term survival (LTS) in patients (pts) with pancreatic cancer is still uncommon, lit...
Objective: To study the impact of perineural growth as a prognostic factor in periampullary adenocar...
Actual 5-year survival rates of 10–18% have been reported for patients with resected pancreatic aden...